Pfizer's Q2 Revenue and Earnings Beat Expectations, as Sales of Pfizer's COVID Antiviral Pill Surpass Estimates

Benzinga
Benzinga
  • 29 days ago
Pfizer's second-quarter revenue and adjusted earnings per share both exceeded analyst estimates, showing a growth from the previous year. Pfizer raised its full-year revenue and adjusted EPS guidance, reflecting increased expectations from earlier projections. Sales of the company's COVID antiviral pill, Paxlovid, increased year over year, beating estimates. Demand has increased in international markets. The company is focusing on cancer treatments following its acquisition of Seagen last year.

Recommended

0:52
I
Up next
Moderna's Q1 Earnings Beat Expectations Despite Covid Vaccine Sales Drop
Benzinga
0:53
Walgreens Posts Strong Quarterly Results Despite Decline in COVID Tests
Benzinga
0:45
Salesforce Beats Earnings and Revenue Expectations
Benzinga
0:41
Exxon Mobil Predicts Fossil Fuels Will Dominate Energy Mix Until 2050, Warns Halting Investment Could Lead to Energy Crisis
Benzinga
0:36
Pharma Bro Martin Shkreli Ordered to Surrender Rare Wu-Tang Clan Album Copies Amid Legal Battle
Benzinga
0:34
Temu Parent PDD Holdings Plummets Nearly 30% After Disappointing Q2 Results. Analyst Says, 'Panic Was Overblown' and May Present a Promising Investment Opportunity
Benzinga
0:32
Merck's Q2 Revenue Beats Expectations on Strong Keytruda and Treatment Sales
Benzinga
0:32
Nvidia Partner Sustainable Metal Cloud Is Capitalizing on AI Demand with Energy-Efficient Cooling Centers That Reduce Consumption by 50%
Benzinga
0:42
Pfizer's Share Price Falls After Disappointing Revenue Forecast
Benzinga
1:17
Donald Trump Unveils New NFT Collection Featuring Debate Memorabilia And Exclusive Perks
Benzinga
0:31
AMD Shares Rebound After Chipmaker Posts Q2 Beat, Guidance Tops Expectations: CEO Lisa Su Says AI Business Accelerating
Benzinga
0:45
J&J's Medical Devices and Pharmaceuticals Drive Impressive Q3 Sales Growth
Benzinga
0:46
Merck Q1 revenue drops by 9% due to steep decline in Covid antiviral sales
Benzinga
0:32
DoorDash Exceeds Revenue Expectations in Q2 Performance, Sees Surge in Total Orders
Benzinga
1:15
AbbVie Sees Increased Drug Sales
Benzinga
0:48
European Travel Company Tui Sees Soaring Stock Price After Reporting 11% Revenue Growth in Full-Year Results
Benzinga
0:38
Eli Lilly's Earnings Soar as Diabetes and Weight Loss Drugs Fuel Blockbuster Quarter
Benzinga
0:39
Target Beats Q2 Earnings Forecast, but Weak Sales Prompt Guidance Downgrade"
Benzinga
0:43
Procter & Gamble Beats Q1 Earnings Estimates
Benzinga
0:41
Salesforce Shares Plummet 18% as Q1 Revenue Falls Short of Estimates. Here's Why Analysts Are Still Optimistic
Benzinga
0:37
Palo Alto Surges 12% on Earnings
Benzinga
0:29
Amazon's Q1 Earnings Exceed Expectations, AI Investments, and Advertising Drive Revenue Growth
Benzinga
0:41
American Airlines reports $10M profit in Q1, a significant boost from last year.
Benzinga
0:37
Uber's Q3 Results Fall Short of Expectations, But Gross Bookings Show Strong Growth
Benzinga
0:35
CVS Health's Q2 Earnings Exceed Expectations, But Slash Full-Year Profit Forecast Due to Higher Medical Costs
Benzinga